Article
Enzalutamide Extends High Health-Related Quality of Life in Metastatic Prostate Cancer
Rating:
0.0
Views:
67
Likes:
1
Library:
1
The addition of enzalutamide to androgen deprivation therapy (ADT) led to maintained health-related quality of life and low symptom burden versus placebo and ADT in men with metastatic castration-sensitive prostate cancer.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value